Tag: FDA Section 505A

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (14)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image Metaxalone MR and Anxiety: Does This Muscle Relaxer Help with Stress and Tension?
recent-post-image Sorrel Supplement: Healing Benefits and Why It Belongs in Your Daily Routine
recent-post-image Aminoglycoside Ototoxicity: How These Antibiotics Cause Permanent Hearing and Balance Loss
recent-post-image How to Confirm Allergies and Interactions at Medication Pickup
recent-post-image Exercise and Statins: What You Need to Know About Muscle Pain and Recovery

Menu

© 2026. All rights reserved.